Charles Weaver, MD, is a pioneering stem cell cancer researcher, developer of the modern practice management industry, strategic oncology consultant, and early advocate and adopter of digital media and social media solutions to enhance community oncology and patient care.

Charles is the CEO and Founder of OMNI Oncology, an early “virtual” digital media company focused on educating community oncologists and empowering patients through internet-based cancer information to seek optimal cancer care, which he has helmed for over 25 years. In addition to education, OMNI provides strategic insights and consulting for clinical trial and drug development, social media solutions, and digital content distribution to a diverse group of clients in oncology including the pharma and medical device industries, hospitals, physician providers, and advocacy groups.

Prior to this, Charles served as the Chief Medical Officer of a Physician Practice Management company and worked to transition stem cell therapies to the private sector, making these therapies more accessible and affordable for patients. He created one of the earliest national clinical trials research networks to perform pivotal clinical trials at community cancer programs, helped pioneer risk based managed care contracting, and developed cancer treatment strategies and educational programs used by over 750 oncologists in the U.S. He remains actively engaged in strategic consulting around all aspects of oncology and cancer care.

Charles earned a Doctor of Medicine degree from the University of Washington and trained at the University of Pennsylvania, National Cancer Institute, and Fred Hutchinson Cancer Research Center. He has authored 75 articles in major medical journals including the New England Journal of Medicine, The Journal of Clinical Oncology, Blood, Cancer, Bone Marrow Transplantation and has lectured at over 100 universities and cancer centers such as the University of London, Stanford, Duke, and Georgetown.